(PWRME, IL, IM, AEE) Stock under Consideration by Stock-PR.com
<p align="center">Stock-PR Reporting</p>
<p align="center"><a title="Stock-PR website" href="stock-pr.com" target="_blank"><img class="alignnone size-full wp-image-2414" title="stockpr_logo-site" alt="stockpr_logo-site" src="stock-pr.com/img/stockpr_logo-site.jpg" /></a></p>
<p align="center"> </p>
<p align="center"><strong><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="pennyomega.com/?page_id=835"></a></strong></p>
<p align="center"><strong><span style="COLOR: black">FREE Daily Stock Alerts From Stock-PR.com</span></strong></p>
<p style="TEXT-ALIGN: center"> </p>
<p align="center"><a title="free stock alerts, best stock alerts, hot stock alerts, stock picks, best stock picks, free stock picks" href="stock-pr.com/?page_id=1085"></a></p>
<p align="center"><span style="COLOR: black"><strong><span style="COLOR: black"><strong><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><a title="stock-pr sign up" href="stock-pr.com/signup" target="_blank"><img height="90" alt="chartstockalert" src="pennyomega.com/img/chartstockalert.jpg" width="360" /></a></span></span></strong></span></strong></span></p>
<p align="center"> </p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong><img style="WIDTH: 176px; HEIGHT: 76px" height="63" alt="power3" hspace="0" src="pennyomega.com/img/power3.png" width="152" align="bottom" border="0" /> Power3 Medical Products, Inc. (PWRME.OB)<br /></strong><br />
Parkinson's disease (PD) is a chronic (persistent) disorder of part of the brain. It mainly affects the way the brain co-ordinates the movements of the muscles in various parts of the body. A small part of the brain called the substantia nigra is mainly affected. This area of the brain sends messages down nerves in the spinal cord to help control the muscles of the body. Messages are passed between brain cells, nerves and muscles by chemicals called neurotransmitters. Dopamine is the main neurotransmitter that is made by the brain cells in the substantia nigra.<br />
<br />
The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black"><strong>Power3 Medical Products, Inc</strong>. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.</font></span></span></span></span></p>
<p><span style="COLOR: black"><span style="COLOR: black"><span style="COLOR: rgb(0,128,255)"><span style="COLOR: rgb(0,128,255)"><font color="black">Please visit Power3 Medical Products, Inc website</font> <a href="www.power3medical.com"><font color="black">www.power3medical.com</font></a><font color="black">.<br />
<br />
*************************************************************************************<br />
<br />
<strong>IntraLinks Holdings, Inc. (NYSE:IL)</strong> announced the appointment of Will Schanz as executive vice president, services. In this newly created position, Schanz will be responsible for the delivery, implementation and overall customer service in support of IntraLinks solutions globally. Schanz brings to IntraLinks a strong expertise in delivering world class, business-to-business (B2B) SaaS-based solutions for leading organizations. "Will is a key addition to our executive management team," said Andrew Damico, president and CEO, IntraLinks. "Will's strong experience in global B2B service delivery will enable us to better support our customers across all areas of the business. His SaaS delivery expertise is particularly important as we continue to drive greater adoption of our solutions into the Enterprise."<br />
<br />
IntraLinks Holdings, Inc. provides critical information exchange solutions. Its solutions include IntraLinks Exchanges, an on-demand workspace solution that facilitates the exchange of critical information, collaboration, and workflow management inside and outside the enterprise; IntraLinks Courier, an enterprise-class managed file transfer solution; Workspace Builder; DCM Compliance Suite, and access gatekeeper services to provide loan investors with compliance management support; and FileSplit that enables mail merged documents to split out and posted to IntraLinks workspaces.<br />
<br />
*****************************************<br />
<br />
<strong>Ingram Micro Inc. (NYSE:IM)</strong> announced financial results for the first quarter of 2011, which ended on April 2, 2011. Worldwide sales were $8.72 billion, a first-quarter record and an 8 percent increase from $8.10 billion reported in the first quarter of last year. The translation effect of foreign currencies had a positive impact of approximately two percentage points on prior-year comparisons. Net income was $56.3 million or $0.34 per diluted share, compared with $70.3 million or $0.42 per diluted share in the 2010 first quarter. The year-over-year decline in income is primarily attributable to difficulties transitioning to a new enterprise system in Australia.<br />
<br />
Ingram Micro Inc. and its subsidiaries distribute information technology (IT) products and supply chain solutions worldwide. The company offers various IT products, including peripherals, systems, software, networking, and others.<br />
<br />
*****************************************<br />
<br />
<strong>Ameren Corporation (NYSE:AEE)</strong> Thomas R. Voss, chairman, president and CEO of Ameren Corp. (NYSE:AEE), will join Martin J. Lyons, senior vice president and CFO of Ameren Corp., to discuss 2011 first quarter financial results and other matters related to the company in a conference call with financial analysts on Thursday, May 5, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The call will be broadcast live over the Internet at</font> <a href="www.ameren.com"><font color="black">ameren.com</font></a><font color="black">. Supporting materials for the call will be posted in the Investors/Webcasts and Presentations area of Ameren's website. A replay of the webcast will be available for one year beginning approximately one hour after the close of the call.<br />
<br />
Ameren Corporation, through its subsidiaries, operates as a public utility holding company in Missouri and Illinois. It engages in the rate-regulated electric generation, transmission, and distribution businesses; rate-regulated natural gas transmission and distribution businesses; and merchant generation businesses.</font></span></span></span></span></p>
<p> </p>
<p align="center"> </p>
<p align="center">**************************************************************</p>
<p align="center"><strong>THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!</strong></p>
<p><strong><font color="blue"><font color="red">Disclaimer:</font> Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (<font color="red">Read more at <a href="stock-pr.com/?page_id=40" target="_blank"><font color="red">stock-pr.com/disclaimer</font></a></font>).</font></strong><span style="COLOR: red"><span style="COLOR: red"><strong><font color="blue">Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.</font><font color="red">Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRME.OB).</font></strong></span></span></p>
<p align="center">Sign Up For Free Stock Alerts At <a href="stock-pr.com/signup" target="_blank">stock-pr.com/signup</a></p>
<p align="center"><a href="www.crownequityholdings.com" target="_blank"><img alt="stock-pr.com/img/stock-pr_buscard.jpg" src="stock-pr.com/img/stock-pr_buscard.jpg" /></a></p>
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.